BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Friday, December 5, 2025
Home » Newsletters » BioWorld Science

BioWorld Science

March 25, 2021

View Archived Issues

Identification and preclinical evaluation of new gamma-secretase modulators to prevent and treat AD

Read More

Brain cell alcohol metabolism affects behavior, addiction

Read More

SF-1 antagonist OR-449 for treating ACC

Read More

Actinium and MSK evaluate Iomab-ACT for targeted conditioning prior to CD19 CAR T-cell therapy

Read More

Ferro Therapeutics synthesizes new PHGPx inhibitors

Read More

HiberCell identifies PERK inhibitors

Read More

Sunshine Lake Pharma presents new TR-beta agonists

Read More

Polivy approved in Japan for relapsed or refractory DLBCL

Read More

Chinese investigators patent TRK inhibitors

Read More

Kochi University discovers new KHSRP inhibitors

Read More

Japanese approval of additional indication for Riona

Read More

Seikagaku obtains approval in Japan for Joyclu intra-articular injection

Read More

Vitrakvi approved in Japan for NTRK fusion-positive advanced or recurrent solid tumors

Read More

Vidaza receives extended approval in Japan for acute myeloid leukemia

Read More

Uplizna gains Japanese approval for the treatment of neuromyelitis optica spectrum disorder

Read More

Corectim Ointment 0.25% and 0.5% approved in Japan as treatment of pediatric atopic dermatitis

Read More

Treakisym in combination with rituximab approved in Japan as treatment of R/R DLBCL

Read More

Microvesicles promote infarct recovery in primates

Read More

Guerbet reports positive phase III data for gadopiclenol

Read More

AstraZeneca reports primary analysis of U.S. phase III trial of AZD-1222

Read More

First patient dosed in phase I study of TH-1902 as treatment of sortilin-positive solid tumors

Read More

Synlogic achieves proof of mechanism for SYNB-8802 in dietary hyperoxaluria study

Read More

Positive topline data from phase II study of NurOwn as treatment of progressive MS

Read More

Phase II/III study of relatlimab with nivolumab in melanoma meets PFS primary endpoint

Read More

KM Biologics reports phase I data on tetravalent dengue vaccine KD-382

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Dec. 4, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Dec. 4, 2025.
  • Green molecules

    UK Biobank delivers largest metabolomics dataset of 500K profiles

    BioWorld Science
    It’s the biological resource that keeps on giving, and now UK Biobank has released the final tranche of data on the levels of 249 metabolites in the blood of its...
  • 3D rendering of prion structure

    Epigenetic technology could eliminate misfolded prion proteins

    BioWorld Science
    The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
  • Mesothelin is biomarker, potential target in arthritic bone damage

    BioWorld Science
    In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing